‘Major advance’: Leukemia treatment could be first US gene therapy – USA TODAY
USA TODAY |
‘Major advance’: Leukemia treatment could be first US gene therapy
USA TODAY A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S.. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of … Gene therapy to kill cancer moves a step closer to marketCNET Pioneering cancer gene therapy by Novartis backed by US panelCNBC Novel leukemia treatment could be 1st US gene therapyABC News CBS News –Reuters –Sun Sentinel –FDA all 101 news articles » |
Local 10 |
Cancer-fighting immunotherapy recommended for FDA approval
Local 10 A panel of experts voted to endorse the immunotherapy drug, known as tisagenlecleucel, which treats a type of leukemia that is more common among children. Ten committee members voted in favor, and one left early without voting. None voted against. ‘Living Drug’ That Fights Cancer By Harnessing Immune System Clears Key HurdleNPR Novel cancer treatment wins endorsement of FDA advisersWashington Post Landmark Novartis Immunotherapy Faces Crucial FDA Hearing WednesdayTheStreet.com BioWorld Online –Chicago Tribune –New York Times –FDA all 140 news articles » |
Local 10 |
Cancer-fighting immunotherapy recommended for FDA approval
Local 10 A panel of experts voted to endorse the immunotherapy drug, known as tisagenlecleucel, which treats a type of leukemia that is more common among children. Ten committee members voted in favor, and one left early without voting. None voted against. ‘Living Drug’ That Fights Cancer By Harnessing The Immune System Clears Key HurdleNPR Novel cancer treatment wins endorsement of FDA advisersWashington Post Landmark Novartis Immunotherapy Faces Crucial FDA Hearing WednesdayTheStreet.com BioWorld Online –Markets Insider –The Nation –Novartis all 86 news articles » |
|
An Exciting New Cancer Treatment Has Just Been Endorsed by FDA
ScienceAlert During the public comment portion of the hearing, Amy Kappen, whose 5-year-old daughter underwent CAR T-cell therapy in Philadelphia, called for approval. The treatment beat back her daughter’s cancer and brought back “the sparkle” in her eyes. |
Weekly Register |
Synthetic Biology Market Headed for Growth and Global Expansion by 2024
Digital Journal Synthetic biology is the advanced technology that is developed from biology, engineering, chemistry, and computer science but the approach was ultimately changed towards therapeutics. The various application of synthetic biology includes industrial … iBio, Inc. (IBIO) Announces US Patent Granted to AzarGen …StreetInsider.com Collaboration Partner Pulls Ibio Inc (NYSEMKT:IBIO) Higher – Stock …StockNewsUnion |
CNET |
Gene therapy to kill cancer moves a step closer to market – CNET
CNET An advisory panel says it’s time patients had access to gene-altering treatments. If approved, the first to make it to market would take on a stubborn form of … |